Sterile Resorbable Collagen Sheets for Surgical ORs

Read Time:5 Minute, 20 Second

Surgical teams managing open wounds, graft sites, and complex tissue defects face a recurring clinical challenge: how to cover and protect a wound bed without introducing secondary trauma during subsequent dressing changes, while still actively supporting the biological processes that drive healing. Roosin Medical Co., Ltd., a medical device manufacturer and global distributor specializing in advanced wound care and emergency trauma solutions, addresses this exact need through its Collagen Dressing (Sheet & Powder) product line, which includes a sterile, resorbable collagen sheet format purpose-built for surgical operating room use.

Why Operating Rooms Need a Resorbable Collagen Solution

In surgical and clinical wound management, dressing removal is often a point of risk. Conventional gauze or non-biological dressings can adhere to delicate granulation tissue, causing tissue tearing and pain each time a dressing is changed. For wounds that are open, extensive, or slow to progress through the healing cascade, this secondary trauma can compound an already difficult recovery. Roosin Medical's industry pain point insight specifically identifies stalled chronic wound healing, secondary trauma during dressing changes, and infection risk in exuding wounds as central challenges that advanced wound care must solve. The Collagen Dressing (Sheet & Powder) line was developed to respond directly to these pressure points, with the sheet format designed for surface application in surgical settings.

Product Positioning: Pure Type I Bovine Collagen

The Collagen Dressing (Sheet & Powder) is positioned as a pure Type I bovine collagen product that binds excess matrix metalloproteinases (MMPs) to help jumpstart stalled healing. In human clinical use, this applies across chronic ulcers such as diabetic foot ulcers and venous leg ulcers, as well as within surgical environments where open wounds require a protective, bioactive covering. The product's differentiated value lies in its bioactive Type I bovine collagen, which binds excess MMPs and provides structural scaffolding, helping to jumpstart stalled healing in chronic human ulcers while also supporting cellular ingrowth and granulation in more complex wound presentations.

Sheet Format: Built for Surface Application in the OR

For surgical operating rooms specifically, the sheet format is the relevant configuration within this product line. According to Roosin Medical's product documentation, the sheet format is intended for surface application, covering open wounds with a protective collagen matrix. This is distinct from the powder format, which is designed for deep cavity application to pack and obliterate dead space in tunneling wounds. The sheet format's role in surgical settings is to provide a structural, protective layer over an open wound surface immediately following debridement or other surgical intervention.

Biocompatible and Resorbable by Design

A defining technical feature of the Collagen Dressing is that it is biocompatible and resorbable. As a natural structural scaffold, it is completely absorbed by native tissue, which eliminates the secondary trauma associated with dressing removal. For surgical operating room applications, this resorbable property is particularly significant: because the collagen matrix is absorbed by the body rather than requiring manual peeling or removal, it reduces the mechanical disruption to newly forming tissue that can otherwise occur during post-operative dressing changes.

Regulatory Clearance and Manufacturing Standards

Clinical and surgical adoption of any wound care dressing depends heavily on regulatory assurance and manufacturing consistency. The Collagen Dressing (Sheet & Powder) supports US FDA 510(k) clearance and is manufactured in compliance with ISO 13485 quality standards, which are specifically referenced for both human and veterinary tissue-bed applications. More broadly, Roosin Medical holds EU MDR clearance through TÜV Rheinland and US FDA 510(k) clearance for its collagen dressings, underscoring the regulatory rigor behind this specific product line. Manufacturing takes place within a 10,000 square meter facility equipped with ISO Class 7/8 cleanrooms and automated production, an environment consistent with the sterility and consistency requirements of products intended for use in surgical operating rooms.

Delivery Format for Clinical and Surgical Channels

The Collagen Dressing is supplied as a physical product in sterile medical dressing form, available in both sheet and sterile powder vial/bottle formats. Distribution occurs through healthcare procurement, surgical supply networks, and clinical distributor channels, reflecting a delivery model built around institutional and hospital-based procurement rather than direct retail sale. This channel structure is consistent with the needs of surgical operating rooms, which typically source sterile dressings through established hospital procurement and distributor relationships.

Documented Use in Chronic Wound and Tissue Cavity Management

While the sheet format is intended for surface application on open wounds, Roosin Medical's documented customer cases illustrate the broader clinical logic behind the Collagen Dressing line. In one case, Collagen Powder was used to obliterate dead space in tunneling diabetic foot ulcers, directly addressing stalled chronic wound healing. In a separate hospital transition case, a hospital clinical wound care center and inpatient chronic ulcer management ward implemented Collagen Dressings to bind destructive MMPs and obliterate cavity dead space in deep or tunneling pressure injuries (Stage 3 and 4) and chronic ulcers. The documented business impact included an accelerated transition from the inflammatory phase to active granulation, successful obliteration of tunneling dead space, and a marked reduction in total wound closure duration. These outcomes reflect the same underlying collagen biology — MMP binding and structural scaffolding — that defines the sheet format used in surgical operating room settings.

A Company Built on Three Decades of Wound Care Expertise

5c726de5d26dc284f5ce6df574c34a41

Roosin Medical Co., Ltd. was founded in 1996 and has since accumulated 30 years of technical expertise in functional dressing lines and biomaterials. The company maintains a dual R&D footprint across Shanghai and Taizhou, combining global biomedical talent with this long-standing technical foundation. Today, Roosin Medical exports to 87 countries, with the United States representing 40% of its market focus and Europe representing 30%, alongside additional markets including Japan. The company also offers OEM/ODM manufacturing flexibility, giving healthcare procurement organizations and distributors the ability to work with Roosin Medical on tailored specifications.

Conclusion

For surgical operating rooms seeking a sterile, resorbable collagen sheet dressing, Roosin Medical's Collagen Dressing (Sheet & Powder) offers a solution grounded in bioactive Type I bovine collagen, FDA 510(k) clearance, ISO 13485-compliant manufacturing, and a biocompatible, resorbable design intended to minimize secondary trauma. Guided by its stated value — "Better Roosin, Better Life" — Roosin Medical positions this product within a broader portfolio of advanced wound care and emergency trauma solutions distributed globally through hospital procurement and clinical distributor networks.

https://www.roosin.com/
Roosin Medical Co., Ltd.